Home | GSK US
The homepage of the GSK USA website
Company | GSK US
Getting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the health of 2.5 billion people by the end of the decade. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive.
Press releases | GSK US
January 10 2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA . If approved, the new presentation will offer a convenient administration option to healthcare professionals.
Vaccines | GSK US
We are leading the way in developing a broad portfolio and innovative pipeline of vaccines to make an impact for society. We deliver over two million vaccine doses per day to people living in over 160 countries.
Purpose, strategy and culture | GSK US
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the of decade, a s a successful, growing company where people can thrive.
Contact us - GSK
Get in touch USA Pennsylvania Address: GSK 2929 Walnut Street Ste. 1700 Philadelphia, PA 19104. North Carolina Address: GSK 410 Blackwell St. Durham, NC 27701
At a glance | GSK US
Over the last two years we have played a key role to develop treatments and vaccines against COVID. Through a partnership with Vir Biotechnology we have developed, and contracted, with the US Government for approximately $1 billion for our monoclonal antibody, Sotrovimab, which demonstrated it can reduce hospitalization and risk of death by 79% in adults with mild-to …
Products | GSK US
Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more product information on our GSKPro website.. In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center.
For media and investors only - GSK
Jun 23, 2021 · At an update to investors today, GlaxoSmithKline plc (GSK LSE & NYSE) will provide details of its strategy, outlook for growth and plans to create shareholder value, following the planned demerger in mid-2022 of its Consumer Healthcare business.
Responsibility | GSK US
Responsible business. At GSK, we’re guided by our purpose to unite science, technology and talent to get ahead of disease together. We deliver this purpose considering the social, environmental and governance impacts across everything we do, from the lab to the patient.